反应详情

To a solution of 40 mg (0.098 mmol) of 3-benzyloxycarbonylamino-3-methyl-N-[2,3,4,5-tetrahydro- 2-oxo-1H-1-benzazepin-3(R)-yl]-butanamide (Example 1, Step F) in 0.5 mL of dry dimethylformamide at room temperature under nitrogen was added 5 mg of 60% sodium hydride oil dispersion (3 mg NaH, 0.13 mmol, 1.3 eq). After 5 minutes, 0.013 mL of benzyl bromide (19 mg, 0.11 mmol, 1.1 eq) was added and the mixture stirred for 1 hour at room temperature, then added to 20 mL of ethyl acetate and washed with water (2×) and brine. The organic layer was removed, dried over magnesium sulfate, filtered and solvents removed under vacuum. The residue was purified by medium pressure liquid chromatography on silica, eluting with ethyl acetate/hexane (1:1) to afford 44 mg (0.88 mmol, 90%) of product. 1H NMR (200 MHz, CDCl3): 1.37 (s,3 H), 1.38 (s,3 H), 1.73 (m,1 H), 2.3-2.6 (m,5 H), 4.48 (m,1 H), 4.80 (d,15 Hz,1 H), 5.07 (br s,2 H), 5.23 (d,15 Hz,1 H), 5.62 (br s,1 H), 6.67 (br d,7 Hz,1H), 7.1-7.4 (m,14 H). FAB-MS: calculated for C30H33N3O4 499; found 500 (M+H,100%).

1. washwashed with water (2×) and brine
2. customThe organic layer was removed
3. dry with materialdried over magnesium sulfate
4. filtrationfiltered
5. customsolvents removed under vacuum
6. customThe residue was purified by medium pressure liquid chromatography on silica
7. washeluting with ethyl acetate/hexane (1:1)